Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)

Aims: Although intensive statin therapy reduced cardiovascular risks, cardiovascular events have not been completely prevented. Probucol is a potent antioxidant and reduces tendon xanthomas in familial hypercholesterolemia patients despite reduction of high-density lipoprotein (HDL)-cholesterol (HDL...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Atheroscler Thromb
मुख्य लेखकों: Yamashita, Shizuya, Arai, Hidenori, Bujo, Hideaki, Masuda, Daisaku, Ohama, Tohru, Ishibashi, Toshiyuki, Yanagi, Koji, Doi, Yasuji, Nakagawa, Satoshi, Yamashiro, Koichi, Tanabe, Kenichiro, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Japan Atherosclerosis Society 2021
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957028/
https://ncbi.nlm.nih.gov/pubmed/32336695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.55327
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन